实验动物与比较医学 ›› 2026, Vol. 46 ›› Issue (1): 55-65.DOI: 10.12300/j.issn.1674-5817.2025.043
姜海涛, 袁韩涛, 黄雯婷, 杨蓉蓉, 陈晓春, 禹宝庆, 李四波(
)(
)
收稿日期:2025-03-17
修回日期:2025-07-31
出版日期:2026-02-25
发布日期:2026-02-14
通讯作者:
李四波(1978—),男,博士,主任医师,从事脊柱退行性病变临床与实验研究。E-mail: 13761603358@163.com。ORCID: 0000-0002-3822-1509作者简介:姜海涛(1985—),男,硕士,主治医师,从事脊柱退行性病变的临床与基础实验研究。E-mail: jianght66@qq.com
基金资助:
JIANG Haitao, YUAN Hantao, HUANG Wenting, YANG Rongrong, CHEN Xiaochun, YU Baoqing, LI Sibo(
)(
)
Received:2025-03-17
Revised:2025-07-31
Published:2026-02-25
Online:2026-02-14
Contact:
LI Sibo (ORCID: 0000-0002-3822-1509), E-mail: 13761603358@163.com摘要:
目的 探讨腰舒逐瘀方调节微RNA-17-5P(microRNA-17-5P,miR-17-5P)/鼠双微基因2(murine double minute 2,MDM2)/p53轴对大鼠椎间盘纤维环细胞增殖和凋亡的影响及潜在分子机制。 方法 取8周龄SPF级雄性SD大鼠的椎间盘纤维环组织,采用酶消化法和机械分散法分离获取纤维环细胞。将纤维环细胞分为6组:C组为空白对照组,纤维环细胞不经白细胞介素-1β(interleukin-1β,IL-1β)处理,直接在RPMI 1640完全培养液中正常培养;β组为10 ng/mL IL-1β处理纤维环细胞24 h构建的退变模型组;β+B组为IL-1β+空白血清组,该组纤维环细胞先经IL-1β处理构建退变模型,后用含5%空白血清的RPMI 1640培养液处理24 h;β+W组为IL-1β+腰舒逐瘀方含药血清组,该组纤维环细胞先经IL-1β处理构建退变模型,后用含5%腰舒逐瘀方含药血清的RPMI 1640培养液处理24 h;β+I组为IL-1β+miR-17-5P inhibitor组,该组纤维环细胞先经IL-1β处理构建退变模型,后转染miR-17-5P inhibitor;β+I+W组为IL-1β+miR-17-5P inhibitor+腰舒逐瘀方含药血清组,该组纤维环细胞先经IL-1β处理构建退变模型,后转染miR-17-5P inhibitor,最后使用含5%腰舒逐瘀方含药血清的RPMI 1640培养液处理24 h。采用CCK-8实验检测各组细胞存活率,流式细胞术检测细胞凋亡情况;采用实时荧光定量PCR检测细胞内miR-17-5P、MDM2 mRNA、p53 mRNA表达量;采用蛋白质印迹法检测细胞中MDM2、p53蛋白表达量。双萤光素酶报告系统分析miR-17-5P和MDM2的靶向关系。 结果 与C组相比,β组细胞存活率显著下降(P<0.001),细胞凋亡率显著升高(P<0.001),miR-17-5P、p53 mRNA及蛋白表达水平显著升高(P<0.001),MDM2 mRNA及蛋白表达水平显著下降(P<0.001)。与β组相比,β+W组、β+I组、β+I+W组细胞存活率显著升高,凋亡率显著下降,miR-17-5P、p53 mRNA及蛋白表达水平显著下降,MDM2 mRNA及蛋白表达水平显著升高(P<0.001),且β+I+W组上述指标的变化幅度更大(P<0.001)。环状RNA相互作用组预测miR-17-5P与MDM2的3'非翻译区(3' untranslated region,3'UTR)有特异性结合位点,转染miR-17-5P模拟物可显著降低与之共转染的含野生型MDM2 3'UTR萤光素酶报告质粒的萤光素酶表达水平(P<0.05),但对含突变型MDM2 3'UTR萤光素酶报告质粒共转染细胞的萤光素酶表达无显著影响(P>0.05)。 结论 腰舒逐瘀方通过下调miR-17-5P水平,促进MDM2蛋白合成,进而下调p53表达,促进大鼠椎间盘纤维环细胞增殖,抑制细胞凋亡。
中图分类号:
姜海涛,袁韩涛,黄雯婷,等. 腰舒逐瘀方通过miR-17-5P/MDM2/p53通路调控大鼠椎间盘纤维环细胞增殖与凋亡[J]. 实验动物与比较医学, 2026, 46(1): 55-65. DOI: 10.12300/j.issn.1674-5817.2025.043.
JIANG Haitao,YUAN Hantao,HUANG Wenting,et al. Regulation of Rat Intervertebral Disc Annulus Fibrosus Cell Proliferation and Apoptosis by Yaoshu Zhuyu Fang via miR-17-5P/MDM2/p53 Pathway[J]. Laboratory Animal and Comparative Medicine, 2026, 46(1): 55-65. DOI: 10.12300/j.issn.1674-5817.2025.043.
腰舒逐瘀方含药血清的体积分数 Concentration of Yaoshu Zhuyu Fang-containing serum | 细胞存活率 Cell survival rate/% |
|---|---|
| 0%(空白对照组) | 100.00±3.24 |
| 0.5% | 45.65±5.23 |
| 1% | 58.69±5.48a |
| 2% | 76.12±8.25ab |
| 5% | 82.44±9.18abc |
| 10% | 68.33±7.41abcd |
表1 不同体积分数的腰舒逐瘀方含药血清对纤维环细胞存活率的影响 (n=6)
Table 1 Effects of different concentrations of Yaoshu Zhuyu Fang-containing serum on annulus fibrosus cell survival rate
腰舒逐瘀方含药血清的体积分数 Concentration of Yaoshu Zhuyu Fang-containing serum | 细胞存活率 Cell survival rate/% |
|---|---|
| 0%(空白对照组) | 100.00±3.24 |
| 0.5% | 45.65±5.23 |
| 1% | 58.69±5.48a |
| 2% | 76.12±8.25ab |
| 5% | 82.44±9.18abc |
| 10% | 68.33±7.41abcd |
引物名称 Primer name | 引物序列(5’→3’) Pimer sequence(5’→3’) |
|---|---|
| miR-17-5P | F:CGGCGCAAGTGGCTTACAG R:TCGAAGGTGCGAGT |
| MDM2 | F:TCTAGGAGATTTGTTTGGCG R:CCTGCTGATTGACTACTACC |
| p53 | F:CCCTGAAGACTGGATAACTGTCA R:CGCTGTGGTGGGCAGAATA |
| GAPDH | F:CCCGCGAGTACAACCTTCTTG R:TCATCCATGGCGAACTGGTGG |
| U6 snRNA | F: CTTCGGCAGCACATATACTAAAAT R: GCTTCACGAATTTGCGTGTCAT |
表2 实时荧光定量PCR引物序列
Table 2 Primer sequences for real-time quantitative PCR
引物名称 Primer name | 引物序列(5’→3’) Pimer sequence(5’→3’) |
|---|---|
| miR-17-5P | F:CGGCGCAAGTGGCTTACAG R:TCGAAGGTGCGAGT |
| MDM2 | F:TCTAGGAGATTTGTTTGGCG R:CCTGCTGATTGACTACTACC |
| p53 | F:CCCTGAAGACTGGATAACTGTCA R:CGCTGTGGTGGGCAGAATA |
| GAPDH | F:CCCGCGAGTACAACCTTCTTG R:TCATCCATGGCGAACTGGTGG |
| U6 snRNA | F: CTTCGGCAGCACATATACTAAAAT R: GCTTCACGAATTTGCGTGTCAT |
组别 Groups | 细胞存活率/% Cell survival rate/% | ||
|---|---|---|---|
| 24 h | 48 h | 72 h | |
空白对照组 Blank control group | 99.78±0.29 | 98.34±1.36 | 98.50±0.83 |
IL-1β诱导退变模型组 IL-1β induced degeneration model group | 45.24±3.69a | 51.18±4.84a | 56.37±6.21a |
IL-1β诱导退变模型+空白血清处理组 IL-1β induced degeneration model + blank serum treated group | 46.12±3.32a | 53.15±5.09a | 58.26±6.18a |
IL-1β诱导退变模型+腰舒逐瘀方含药血清处理组 IL-1β induced degeneration model + Yaoshu Zhuyu Fang-containing serum treated group | 52.35±3.12abc | 60.24±5.05abc | 66.39±7.61abc |
IL-1β诱导退变模型+miR-17-5P inhibitor转染组 IL-1β induced degeneration model + miR-17-5P inhibitor transfected group | 54.22±4.15abc | 63.48±5.13abc | 68.06±7.95abc |
IL-1β诱导退变模型+miR-17-5P inhibitor转染+腰舒逐瘀方含药血清处理组 IL-1β induced degeneration model + miR-17-5P inhibitor transfection + Yaoshu Zhuyu Fang-containing serum treated group | 60.64±4.13abcde | 70.96±6.01abcde | 78.14±3.17abcde |
表3 腰舒逐瘀方含药血清对大鼠椎间盘退变纤维环细胞存活率的影响 (n=6)
Table 3 Effects of Yaoshu Zhuyu Fang-containing serum on survival rate of rat degenerated intervertebral disc annulus fibrosus cells
组别 Groups | 细胞存活率/% Cell survival rate/% | ||
|---|---|---|---|
| 24 h | 48 h | 72 h | |
空白对照组 Blank control group | 99.78±0.29 | 98.34±1.36 | 98.50±0.83 |
IL-1β诱导退变模型组 IL-1β induced degeneration model group | 45.24±3.69a | 51.18±4.84a | 56.37±6.21a |
IL-1β诱导退变模型+空白血清处理组 IL-1β induced degeneration model + blank serum treated group | 46.12±3.32a | 53.15±5.09a | 58.26±6.18a |
IL-1β诱导退变模型+腰舒逐瘀方含药血清处理组 IL-1β induced degeneration model + Yaoshu Zhuyu Fang-containing serum treated group | 52.35±3.12abc | 60.24±5.05abc | 66.39±7.61abc |
IL-1β诱导退变模型+miR-17-5P inhibitor转染组 IL-1β induced degeneration model + miR-17-5P inhibitor transfected group | 54.22±4.15abc | 63.48±5.13abc | 68.06±7.95abc |
IL-1β诱导退变模型+miR-17-5P inhibitor转染+腰舒逐瘀方含药血清处理组 IL-1β induced degeneration model + miR-17-5P inhibitor transfection + Yaoshu Zhuyu Fang-containing serum treated group | 60.64±4.13abcde | 70.96±6.01abcde | 78.14±3.17abcde |
图2 流式细胞术检测各组干预对大鼠椎间盘退变纤维环细胞凋亡的影响注:A,检测各组细胞凋亡的流式细胞术散点图;B,各组细胞凋亡率统计图。C组为空白对照组;β组为白细胞介素-1β(IL-1β)诱导退变模型组;β+B组为IL-1β诱导退变模型+空白血清处理组;β+W组为IL-1β诱导退变模型+腰舒逐瘀方含药血清处理组;β+I组为IL-1β诱导退变模型+miR-17-5P inhibitor转染组;β+I+W组为IL-1β诱导退变模型+miR-17-5P inhibitor转染+腰舒逐瘀方含药血清处理组。每组6只大鼠。***与C组比较,P<0.001;###与β组比较,P<0.001;$$$与β+W和β+I组比较,P<0.001。
Figure 2 Effects of interventions in each group on apoptosis of rat degenerated intervertebral disc annulus fibrosus cells detected by flow cytometryNote: A, Flow cytometry results for apoptosis detection of cells in each group; B, Apoptosis rates statistical result of cells in each group. C group is the blank control group; β group is interleukin-1β (IL-1β) induced degeneration model group; β+B group is IL-1β induced degeneration model + blank serum treated group; β+W group is IL-1β induced degeneration model + Yaoshu Zhuyu Fang-containing serum treated group; β+I group is IL-1β induced degeneration model + miR-17-5P inhibitor transfected group; β+I+W group is IL-1β induced degeneration model + miR-17-5P inhibitor transfection +Yaoshu Zhuyu Fang-containing serum treated group. n=6; *** Compared with C group, P<0.001; ### Compared with β group, P<0.001; $$$ Compared with β+W group and β+I group, P<0.001.
图3 各组干预对大鼠椎间盘纤维环细胞miR-17-5P、MDM2、p53表达的影响注:A,检测各组大鼠椎间盘纤维环细胞中微RNA-17-5P(miR-17-5P)、鼠双微基因2(MDM2)mRNA与p53 mRNA水平的实时荧光定量PCR结果;B~C,检测各组大鼠椎间盘纤维环细胞中MDM2、p53蛋白表达的蛋白质印迹结果和统计分析结果。C组为空白对照组;β组为白细胞介素-1β(IL-1β)诱导退变模型组;β+B组为IL-1β诱导退变模型+空白血清处理组;β+W组为IL-1β诱导退变模型+腰舒逐瘀方含药血清处理组;β+I组为IL-1β诱导退变模型+miR-17-5P inhibitor转染组;β+I+W组为IL-1β诱导退变模型+miR-17-5P inhibitor转染+腰舒逐瘀方含药血清处理组。每组6只大鼠。*** 与C组比较,P<0.001;###与β组比较,P<0.001;$$$与β+W和β+I组比较,P<0.001。
Figure 3 Effects of interventions in each group on expression of miR-17-5P, MDM2, and p53 in rat intervertebral disc annulus fibrosus cellsNote: A,Quantitative real-time PCR results of microRNA-17-5P (miR-17-5P), murine double minute 2 (MDM2) mRNA and p53 mRNA expression in rat intervertebral disc annulus fibrosus cells from each group; B and C, Western blotting result and statistical analysis result of MDM2 and p53 protein expression in each group rat intervertebral disc annulus fibrosus cells. C group is the blank control group; β group is interleukin-1β (IL-1β) induced degeneration model group; β+B group is IL-1β induced degeneration model + blank serum treated group; β+W group is IL-1β induced degeneration model + Yaoshu Zhuyu Fang-containing serum treated group; β+I group is IL-1β induced degeneration model + miR-17-5P inhibitor transfected group; β+I+W group is IL-1β induced degeneration model + miR-17-5P inhibitor transfection +Yaoshu Zhuyu Fang-containing serum treated group. n=6; *** Compared with C group, P<0.001; ### Compared with β group, P<0.001; $$$ Compared with β+W group and β+I group, P<0.001.
图4 环状RNA相互作用组预测miR-17-5P和MDM2的靶向关系注:MDM2,鼠双微基因2;3'UTR,3'非翻译区;miR-17-5P,微RNA-17-5P;WT,野生型;MUT,突变型。
Figure 4 Targeting relationship between miR-17-5P and MDM2 predicted byCircular RNA InteractomeNote: MDM2, murine double minute 2; 3'UTR, 3' untranslated region; miR-17-5P, microRNA-17-5P; WT, wiede type; MUT, mutant type.
组别 Groups | MDM2⁃WT组 MDM2⁃WT group | MDM2⁃MUT组 MDM2⁃MUT group |
|---|---|---|
转染miR-17-5P阴性对照 Transfecting miR-17-5P negative control | 1.00±0.10 | 1.00±0.11 |
转染miR-17-5P 模拟物 Transfecting miR-17-5P mimics | 0.43±0.05 | 1.02±0.10 |
| t | 12.488 | 0.330 |
| P | <0.001 | 0.749 |
表4 双萤光素酶报告基因实验验证miR-17-5P与MDM2的靶向关系 (n=6)
Table 4 Targeting relationship between miR-17-5P and MDM2 detected by luciferase reporter assay
组别 Groups | MDM2⁃WT组 MDM2⁃WT group | MDM2⁃MUT组 MDM2⁃MUT group |
|---|---|---|
转染miR-17-5P阴性对照 Transfecting miR-17-5P negative control | 1.00±0.10 | 1.00±0.11 |
转染miR-17-5P 模拟物 Transfecting miR-17-5P mimics | 0.43±0.05 | 1.02±0.10 |
| t | 12.488 | 0.330 |
| P | <0.001 | 0.749 |
| [1] | SAMANTA A, LUFKIN T, KRAUS P. Intervertebral disc degeneration–Current therapeutic options and challenges[J]. Front Public Health, 2023, 11:1156749. DOI:10.3389/fpubh. 2023.1156749 . |
| [2] | SONG Q W, LIU X Q, CHEN D J, et al. Evaluation of MRI and CT parameters to analyze the correlation between disc and facet joint degeneration in the lumbar three-joint complex[J]. Medicine (Baltimore), 2019, 98(40): e17336. DOI:10.1097/MD.0000000000017336 . |
| [3] | PAN H Y, LI H T, GUO S, et al. The mechanisms and functions of TNF-α in intervertebral disc degeneration[J]. Exp Gerontol, 2023, 174:112119. DOI:10.1016/j.exger.2023.112119 . |
| [4] | SILWAL P, NGUYEN-THAI A M, MOHAMMAD H A, et al. Cellular senescence in intervertebral disc aging and degeneration: molecular mechanisms and potential therapeutic opportunities[J]. Biomolecules, 2023, 13(4):686. DOI:10.3390/biom13040686 . |
| [5] | SWAHN H, MERTENS J, OLMER M, et al. Shared and compartment-specific processes in nucleus pulposus and annulus fibrosus during intervertebral disc degeneration[J]. Adv Sci (Weinh), 2024, 11(17): e2309032. DOI:10.1002/advs. 202309032 . |
| [6] | GHAFFARPASAND F, SARHADI S, ALAVI M H, et al. Modifications of miRNAs in intervertebral disc degeneration: a key to the future development of genetic-based therapies[J]. Epigenomics, 2023, 15(5):271-281. DOI:10.2217/epi-2022-0277 . |
| [7] | GENEDY H H, HUMBERT P, LAOULAOU B, et al. microRNA-targeting nanomedicines for the treatment of intervertebral disc degeneration[J]. Adv Drug Deliv Rev, 2024, 207:115214. DOI:10.1016/j.addr.2024.115214 . |
| [8] | BRUMMER T, ZEISER R. The role of the MDM2/p53 axis in antitumor immune responses[J]. Blood, 2024, 143(26):2701-2709. DOI:10.1182/blood.2023020731 . |
| [9] | 卢今, 张颖, 潘学营, 等. 2020版 美国兽医协会动物安乐死指南解析[J]. 实验动物与比较医学, 2021, 41(3):195-206. DOI:10.12300/j.issn.1674-5817.2021.086 . |
| LU J, ZHANG Y, PAN X Y, et al. A brief interpretation of AVMA guidelines on euthanasia of animals: 2020 edition[J]. Lab Anim Comp Med, 2021, 41(3):195-206. DOI:10.12300/j.issn.1674-5817.2021.086 . | |
| [10] | 刘飞祥, 谭峰, 樊巧玲, 等. CCK-8与MTT法检测左归丸含药血清干预BMSCs增殖条件的比较[J]. 中国骨质疏松杂志, 2022, 28(1):6-10. DOI:10.3969/j.issn.1006-7108.2022.01.002 . |
| LIU F X, TAN F, FAN Q L, et al. Comparative study on experiment conditions between CCK-8 and MTT assay on BMSCs proliferation intervened by serum containing Zuoguiwan[J]. Chin J Osteoporos, 2022, 28(1):6-10. DOI:10.3969/j.issn.1006-7108.2022.01.002 . | |
| [11] | 朱晓雨, 袁韩涛, 李四波. 微RNA-887-3p能抑制大鼠椎间盘纤维环细胞中MDM4表达和细胞增殖并促进细胞凋亡[J].实验动物与比较医学, 2024, 44(3):270-278. DOI:10.12300/j.issn.1674-5817.2024.003 . |
| ZHU X Y, YUAN H T, LI S B. MicroRNA-887-3p inhibited MDM4 expression and proliferation but promoted apoptosis of intervertebral disc annulus fibrosus cells in rats[J]. Lab Anim Comp Med, 2024, 44(3):270-278. DOI:10.12300/j.issn.1674-5817.2024.003 . | |
| [12] | ZHAO C Q, LIU D, LI H, et al. Interleukin-1beta enhances the effect of serum deprivation on rat annular cell apoptosis[J]. Apoptosis, 2007, 12(12):2155-2161. DOI:10.1007/s10495-007-0137-x . |
| [13] | YURUBE T, TAKEOKA Y, KANDA Y, et al. Intervertebral disc cell fate during aging and degeneration: apoptosis, senescence, and autophagy[J]. N Am Spine Soc J, 2023, 14:100210. DOI:10.1016/j.xnsj.2023.100210 . |
| [14] | LAMA P, TIWARI J, MUTREJA P, et al. Cell clusters in intervertebral disc degeneration: an attempted repair mechanism aborted via apoptosis[J]. Anat Cell Biol, 2023, 56(3):382-393. DOI:10.5115/acb.23.067 . |
| [15] | ZOU M X, CHEN W K, LI J, et al. Apoptosis signal-regulated kinase-1 promotes nucleus pulposus cell senescence and apoptosis to regulate intervertebral disc degeneration[J]. Am J Pathol, 2024, 194(9):1737-1751. DOI:10.1016/j.ajpath.2024. 05.004 . |
| [16] | 庄子豪, 戚晓楠, 崔海舰, 等. 基于数据挖掘分析中药复方防治腰椎间盘退行性疾病组方规律[J/OL]. 实用中医内科杂志, 2024:1-12. (2024-09-26). . |
| ZHUANG Z H, QI X N, CUI H J, et al. Data mining analysis of the formulation rules for traditional Chinese medicine compounds in the prevention and treatment of degenerative diseases of the lumbar intervertebral disc[J/OL]. J Pract Tradit Chin Intern Med, 2024:1-12. (2024-09-26). . | |
| [17] | 朱炯, 马雪建, 岳宗进, 等. 基于网络药理学和分子对接探讨独活寄生汤治疗腰椎间盘突出症的作用机制[J]. 颈腰痛杂志, 2025, 46(1):93-99. DOI:10.3969/j.issn.1005-7234.2025.01.018 . |
| ZHU J, MA X J, YUE Z J, et al. Exploring the mechanism of action of Duhuo Jisheng Decoction in treating lumbar disc herniation based on network pharmacology and molecular docking[J]. J Cervicodynia Lumbodynia, 2025, 46(1):93-99. DOI:10.3969/j.issn.1005-7234.2025.01.018 . | |
| [18] | 马博, 李慧英, 孟东方, 等. 身痛逐瘀汤联合经皮椎间孔镜治疗腰椎间盘突出症的效果[J]. 西北药学杂志, 2024, 39(1):139-142. DOI:10.3969/j.issn.1004-2407.2024.01.023 . |
| MA B, LI H Y, MENG D F, et al. Effect of Shentong Zhuyu Decoction combined with percutaneous transforaminal endoscopic in the treatment of lumbar disc herniation[J]. Northwest Pharm J, 2024, 39(1):139-142. DOI:10.3969/j.issn.1004-2407.2024.01.023 . | |
| [19] | 崔海舰. 身痛逐瘀汤治疗腰椎间盘突出症临床研究及延缓椎间盘退变实验研究[D]. 沈阳: 辽宁中医药大学, 2025. DOI:10.27213/d.cnki.glnzc.2024.000024 . |
| CUI H J. Clinical Research on the treatment of lumbar intervertebral disc herniation with Shentong Zhuyu decoction and experimental study on the delay of intervertebral disc degeneration[D]. Shenyang: Liaoning University of Traditional Chinese Medicine, 2025. DOI:10.27213/d.cnki.glnzc.2024.000024 . | |
| [20] | 丁琳, 穆姿辰, 刘欣欣, 等. 身痛逐瘀汤治疗骨关节病变的研究进展[J]. 长春中医药大学学报, 2023, 39(2):217-222. DOI: 10.13463/j.cnki.cczyy.2023.02.023 . |
| DING L, MU Z C, LIU X X, et al. Research progress of Shentong Zhuyu decoction in the treatment of osteoarthritis[J]. J Changchun Univ Chin Med, 2023, 39(2):217-222. DOI: 10.13463/j.cnki.cczyy.2023.02.023 . | |
| [21] | 于大伟. 身痛逐瘀汤联合脉冲射频治疗气滞血瘀型腰椎间盘突出症的回顾性研究[D]. 天津: 天津中医药大学, 2023. DOI:10.27368/d.cnki.gtzyy.2023.000009 . |
| YU D W. A retrospective study on the treatment of lumbar intervertebral disc protrusion of qi stagnation and blood stasis type with Shentong Zhuyu decoction combined with pulsed radiofrequency[D]. Tianjin: Tianjin University of Traditional Chinese Medicine, 2023. DOI:10.27368/d.cnki.gtzyy.2023.000009 . | |
| [22] | LORUSSO P, YAMAMOTO N, PATEL M R, et al. The MDM2-p53 antagonist brigimadlin (BI 907828) in patients with advanced or metastatic solid tumors: results of a phase Ⅰa, first-in-human, dose-escalation study[J]. Cancer Discov, 2023, 13(8):1802-1813. DOI:10.1158/2159-8290.CD-23-0153 . |
| [23] | POUREBRAHIM R, MONTOYA R H, ALANIZ Z, et al. Mdm2/p53 levels in bone marrow mesenchymal stromal cells are essential for maintaining the hematopoietic niche in response to DNA damage[J]. Cell Death Dis, 2023, 14(6):371. DOI: 10.1038/s41419-023-05844-7 . |
| [24] | WANG Y D, HU S Y, ZHANG W S, et al. Emerging role and therapeutic implications of p53 in intervertebral disc degeneration[J]. Cell Death Discov, 2023, 9(1):433. DOI:10.1038/s41420-023-01730-5 . |
| [25] | ZHOU C C, YAO S, FU F D, et al. Morroniside attenuates nucleus pulposus cell senescence to alleviate intervertebral disc degeneration via inhibiting ROS-Hippo-p53 pathway[J]. Front Pharmacol, 2022, 13:942435. DOI:10.3389/fphar.2022. 942435 . |
| [26] | 周年, 胡侦明, 林鑫, 等. SIRT1去乙酰化修饰p53抑制IL-1β介导的软骨终板细胞衰老[J]. 第三军医大学学报, 2018, 40(22):2040-2046. DOI: 10.16016/j.1000-5404.201806002 . |
| ZHOU N, HU Z M, LIN X, et al. SIRT1 inhibits interleukin-1β-mediated cartilage end plate cell senescence via p53 deacetylation[J]. J Third Mil Med Univ, 2018, 40(22):2040-2046. DOI: 10.16016/j.1000-5404.201806002 . |
| [1] | 曹星新, 李艾亦, 侯婧涵, 李明学, 李艳艳, 靳玮华, 杨凤梅, 段素琴, 和占龙. 黄芪或其成分治疗急性胰腺炎的动物实验Meta分析[J]. 实验动物与比较医学, 2025, 45(5): 561-573. |
| [2] | 高超奇, 祝志波, 孙显东. 大鼠血管重构模型的应用进展与分类分析[J]. 实验动物与比较医学, 2025, 45(5): 542-550. |
| [3] | 罗一凡, 张臻玮, 梅璐, 史叶萍, 邢艺彤, 张泽奇, 李楚欣, 韩春霞, 杨平顺, 陈秋生. 特络细胞介导肥胖症大鼠膏摩寡肽中草药复合制剂的减肥作用及其机制[J]. 实验动物与比较医学, 2025, 45(5): 551-560. |
| [4] | 秦超, 李双星, 赵婷婷, 蒋晨晨, 赵晶, 杨艳伟, 林志, 王三龙, 文海若. 药物安全评价用SD大鼠90 d喂养试验的背景数据研究[J]. 实验动物与比较医学, 2025, 45(4): 439-448. |
| [5] | 刘力瑜, 嵇波, 刘小玄, 方洋, 张玲, 郭亭廷, 全烨, 李鹤文, 刘翼天. 大鼠胎儿期肺组织固定方法的探索[J]. 实验动物与比较医学, 2025, 45(4): 432-438. |
| [6] | 肖林林, 杨逸萱, 黎珊杉, 罗兰诗雨, 尹思威, 孙俊铭, 施维, 欧阳轶强, 李习艺. 利用脑立体定位技术将人源三突变APP基因导入海马区构建阿尔茨海默病大鼠模型[J]. 实验动物与比较医学, 2025, 45(3): 269-278. |
| [7] | 潘颐聪, 蒋汶洪, 胡明, 覃晓. 慢性肾脏病大鼠主动脉钙化模型的术式优化及效果评价[J]. 实验动物与比较医学, 2025, 45(3): 279-289. |
| [8] | 刘智伟, 杨然, 连浩, 张玉, 金立伦. 秦皮素对碘乙酸钠诱导骨关节炎模型大鼠的软骨保护与抗炎作用[J]. 实验动物与比较医学, 2025, 45(3): 259-268. |
| [9] | 姜萌, 郝淑兰, 仝立国, 仲启明, 高振飞, 王永辉, 王晞星, 吉海杰. 长春瑞滨诱导大鼠足背静脉炎模型的动态评价[J]. 实验动物与比较医学, 2025, 45(3): 251-258. |
| [10] | 连辉, 姜艳玲, 刘佳, 张玉立, 谢伟, 薛晓鸥, 李健. 异常子宫出血大鼠模型的构建与评价[J]. 实验动物与比较医学, 2025, 45(2): 130-146. |
| [11] | 孙效容, 苏丹, 贵文娟, 陈玥. 手术诱导大鼠中重度膝骨关节炎模型的建立与评价[J]. 实验动物与比较医学, 2024, 44(6): 597-604. |
| [12] | 殷玉莲, 马丽娜, 屠思远, 陈玲, 叶媚娜, 陈红风. 非哺乳期乳腺炎大鼠模型的建立及评价[J]. 实验动物与比较医学, 2024, 44(6): 587-596. |
| [13] | 杨劲, 俞诗雅, 林楠, 方永超, 赵虎, 邱锦维, 林鸿铭, 陈惠燕, 王瑜, 吴伟航. 改良型十二指肠旷置术对2型糖尿病大鼠糖代谢的影响[J]. 实验动物与比较医学, 2024, 44(5): 523-530. |
| [14] | 戚龙菊, 陈世园, 廖泽华, 石袁虎, 孙郁雨, 王庆华. 经血干细胞移植联合运动训练促进大鼠脊髓损伤康复的转录组学分析[J]. 实验动物与比较医学, 2024, 44(5): 531-542. |
| [15] | 张乃群, 袁飘漂, 曹琳茸, 应娜, 杨涛涛. PNR检测在糖尿病肾脏疾病模型大鼠诊断及药效评价中的应用[J]. 实验动物与比较医学, 2024, 44(5): 543-549. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||